These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2959472)

  • 21. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of in vitro susceptibility of mycobacteria to ansamycin.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sensitivity of 7 mycobacterial species to new quinolones].
    Gevaudan MJ; Mallet MN; Gulian C; Terriou P; Lagier P; de Micco P
    Pathol Biol (Paris); 1988 May; 36(5):477-81. PubMed ID: 3136429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Susceptibility of intra- and extracellular Mycobacterium avium-intracellulare to cephem antibiotics.
    Nozawa RT; Kato H; Yokota T; Sugi H
    Antimicrob Agents Chemother; 1985 Jan; 27(1):132-4. PubMed ID: 3985594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
    Tsukamura M
    Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin.
    Casal M; Rodriguez F; Benavente M; Luna M
    Eur J Clin Microbiol; 1986 Aug; 5(4):453-4. PubMed ID: 3093225
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibacterial activities of dendritic amphiphiles against nontuberculous mycobacteria.
    Falkinham JO; Macri RV; Maisuria BB; Actis ML; Sugandhi EW; Williams AA; Snyder AV; Jackson FR; Poppe MA; Chen L; Ganesh K; Gandour RD
    Tuberculosis (Edinb); 2012 Mar; 92(2):173-81. PubMed ID: 22209468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.
    Marinis E; Legakis NJ
    J Antimicrob Chemother; 1985 Oct; 16(4):527-30. PubMed ID: 2933382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In vitro sensitivity of Mycobacterium avium and Mycobacterium xenopi to erythromycin, roxithromycin and doxycycline].
    Maugein J; Fourche J; Mormede M; Pellegrin JL
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):565-7. PubMed ID: 2797881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of the effects of chlorhexidine diacetate and cetylpyridinium chloride on mycobacteria by ethambutol.
    Broadley SJ; Jenkins PA; Furr JR; Russell AD
    J Med Microbiol; 1995 Dec; 43(6):458-60. PubMed ID: 7473681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New antimycobacterial 2,3-dihydro-1-alkylindole-2-thiones.
    Waisser K; Heinisch L; Slosárek M; Janota J
    Folia Microbiol (Praha); 2006; 51(1):25-6. PubMed ID: 16821707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic susceptibility of Mycobacterium marinum.
    Forsgren A
    Scand J Infect Dis; 1993; 25(6):779-82. PubMed ID: 8052821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of the in vitro antimycobacterial activities of six aminoglycoside antibiotics using an agar dilution method.
    Udou T
    J Chemother; 2006 Dec; 18(6):610-6. PubMed ID: 17267338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.
    Swenson JM; Wallace RJ; Silcox VA; Thornsberry C
    Antimicrob Agents Chemother; 1985 Dec; 28(6):807-11. PubMed ID: 4083863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vitro activities of quinolones against mycobacteria.
    Garcia-Rodriguez JA; Gomez Garcia AC
    J Antimicrob Chemother; 1993 Dec; 32(6):797-808. PubMed ID: 8144420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro susceptibility of mycobacteria, especially of Mycobacterium intracellulare, to 5-fluorouracil and pattern of development of resistance of Mycobacterium tuberculosis to the drug.
    Tsukamura M
    Microbiol Immunol; 1979; 23(5):427-9. PubMed ID: 116112
    [No Abstract]   [Full Text] [Related]  

  • 39. Absence of a functional erm gene in isolates of Mycobacterium immunogenum and the Mycobacterium mucogenicum group, based on in vitro clarithromycin susceptibility.
    Brown-Elliott BA; Hanson K; Vasireddy S; Iakhiaeva E; Nash KA; Vasireddy R; Parodi N; Smith T; Gee M; Strong A; Barker A; Cohen S; Muir H; Slechta ES; Wallace RJ
    J Clin Microbiol; 2015 Mar; 53(3):875-8. PubMed ID: 25568437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin).
    Tsukamura M
    Microbiol Immunol; 1986; 30(9):931-3. PubMed ID: 3467156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.